Laurent Weekers1, Pauline Vanderweckene1, Hans Pottel2, Diego Castanares-Zapatero3, Catherine Bonvoisin1, Etienne Hamoir4, Sylvie Maweja4, Jean-Marie Krzesinski1, Pierre Delanaye1, François Jouret1,5. 1. Division of Nephrology, Department of Internal Medicine, University of Liège Hospital (ULg CHU), Liège, Belgium. 2. KU Leuven Kulak, Department of Public Health and Primary Care, University of Leuven, Kortrijk, Belgium. 3. Intensive Care Unit, Cliniques universistaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. 4. Division of Abdominal Surgery and Transplantation, Department of Surgery, University of Liège Hospital (ULg CHU), Liège, Belgium. 5. Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Cardiovascular Sciences, University of Liège, Liège, Belgium.
Abstract
Background: The creation of arteriovenous fistula (AVF) may retard chronic kidney disease progression in the general population. Conversely, the impact of AVF closure on renal function in kidney transplant recipients (KTRs) remains unknown. Methods: From 2007 to 2013, we retrospectively categorized 285 KTRs into three groups: no AVF (Group 0, n = 90), closed AVF (Group 1, n = 114) and left-open AVF (Group 2, n = 81). AVF closure occurred at 653 ± 441 days after kidney transplantation (KTx), with a thrombosis:ligation ratio of 19:95. Estimated glomerular filtration rate (eGFR) was determined using the Modification of Diet in Renal Disease equation. Linear mixed models calculated the slope and intercept of eGFR decline versus time, starting at 3 months post-KTx, with a median follow-up of 1807 days (95% confidence interval 1665-2028). Results: The eGFR slope was less in Group 1 (-0.081 mL/min/month) compared with Group 0 (-0.183 mL/min/month; P = 0.03) or Group 2 (-0.164 mL/min/month; P = 0.09). Still, the eGFR slope significantly deteriorated after (-0.159 mL/min/month) versus before (0.038 mL/min/month) AVF closure (P = 0.03). Study periods before versus after AVF closure were balanced to a mean of 13.5 and 12.5 months, respectively, with at least 10 observations per patient ( n = 99). Conclusions: In conclusion, a significant acceleration of eGFR decline is observed over the 12 months following the closure of a functioning AVF in KTRs.
Background: The creation of arteriovenous fistula (AVF) may retard chronic kidney disease progression in the general population. Conversely, the impact of AVF closure on renal function in kidney transplant recipients (KTRs) remains unknown. Methods: From 2007 to 2013, we retrospectively categorized 285 KTRs into three groups: no AVF (Group 0, n = 90), closed AVF (Group 1, n = 114) and left-open AVF (Group 2, n = 81). AVF closure occurred at 653 ± 441 days after kidney transplantation (KTx), with a thrombosis:ligation ratio of 19:95. Estimated glomerular filtration rate (eGFR) was determined using the Modification of Diet in Renal Disease equation. Linear mixed models calculated the slope and intercept of eGFR decline versus time, starting at 3 months post-KTx, with a median follow-up of 1807 days (95% confidence interval 1665-2028). Results: The eGFR slope was less in Group 1 (-0.081 mL/min/month) compared with Group 0 (-0.183 mL/min/month; P = 0.03) or Group 2 (-0.164 mL/min/month; P = 0.09). Still, the eGFR slope significantly deteriorated after (-0.159 mL/min/month) versus before (0.038 mL/min/month) AVF closure (P = 0.03). Study periods before versus after AVF closure were balanced to a mean of 13.5 and 12.5 months, respectively, with at least 10 observations per patient ( n = 99). Conclusions: In conclusion, a significant acceleration of eGFR decline is observed over the 12 months following the closure of a functioning AVF in KTRs.
Authors: Tania Salehi; Nicholas J Montarello; Nishant Juneja; Michael B Stokes; Daniel J Scherer; Kerry F Williams; David King; Ewan Macaulay; Christine H Russell; Santosh A Olakkengil; Robert P Carroll; Randall J Faull; Karen S L Teo; Stephen P McDonald; Matthew I Worthley; Patrick T Coates; Nitesh N Rao Journal: Kidney360 Date: 2021-05-18
Authors: Patrick Hetz; Markus Pirklbauer; Silvana Müller; Lydia Posch; Maria Gummerer; Martin Tiefenthaler Journal: Am J Nephrol Date: 2020-07-13 Impact factor: 3.754
Authors: Bram M Voorzaat; Cynthia J Janmaat; Esther D Wilschut; Koen Ea Van Der Bogt; Friedo W Dekker; Joris I Rotmans Journal: J Vasc Access Date: 2018-05-30 Impact factor: 2.283